Nerlynx 40 mg
Nerlynx 40 mg is a medicine authorised by Swissmedic under authorisation number 67293. The authorisation holder is Pierre Fabre Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 March 2020 and the authorisation is valid without a time limit. ATC code L01EH02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67293 |
|---|---|
| Name | Nerlynx 40 mg |
| Full name | Nerlynx 40 mg, Filmtabletten |
| Authorisation holder | Pierre Fabre Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EH02 |
| First authorisation | 20 March 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nerlynx 40 mg, Filmtabletten | A | 20 March 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 180 | Tablette(n) | L01EH02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Nerlynx 40 mg authorised in Switzerland?
Yes. Nerlynx 40 mg is authorised by Swissmedic under authorisation number 67293, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nerlynx 40 mg have?
Nerlynx 40 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Nerlynx 40 mg?
The authorisation holder is Pierre Fabre Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.